"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"
|Starts||1:45pm on Friday, October 12th 2012|
|Ends||2:45pm on Friday, October 12th 2012|
|Location||670 Albany Street Room #107/108|
|Contact Name||Deb Kiley|
|Contact Phone||617 414 7914|
|Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD Director of Developmental Therapeutics Massachusetts General Hospital Cancer Center Harvard Medical School|